LSP 3
Investments range between 5 million EUR and 15 million EUR.
LSP 3 seeks to invest in early-to-late-stage life sciences companies, developing novel and ground-breaking new medicines and technologies that provide solutions to unmet medical needs. LSP 3’s geographical focus is primarily Europe and occasionally the US.
Key Facts
- Status
Active
- Launch
2005
- Size
141M EUR
- SFDR classification
-
Head of fund
EQT Fund Management S.à r.l.
51A Boulevard Royal
L-2449, Luxembourg
Luxembourg
Company Registration Number: RCS B 167 972
EQT Fund Management S.à r.l. is an alternative investment fund manager authorized and regulated in accordance with the Luxembourg law of 12 July 2013.
The Team
News
Do You Want to Learn More?
We are eager to explore how we can achieve great things together.